Axitinib, a revolutionary targeted therapy for advanced renal cell carcinoma (RCC) and other cancers, has transformed treatment landscapes. However, ensuring the consistent quality and safety of this life-saving medication necessitates meticulous attention to detail throughout the Active Pharmaceutical Ingredient (API) manufacturing process.  This blog post delves into the complexities of...